Increased production of biofilms by Escherichia coli in the presence of enrofloxacin

Veterinary Microbiology

Volumn 160, Issue 3-4, 2012, Pages 488-490

  Costa, João Carlos Miguel ^a   Espeschit, Isis de Freitas ^a   Pieri, Fábio Alessandro ^a   Benjamin, Laércio dos Anjos ^a   Moreira, Maria Aparecida Scatamburlo ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Biofilms; Escherichia coli; Induction; Quinolone

Indexed keywords

ENROFLOXACIN;

ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATE; BIOFILM; COW; ESCHERICHIA COLI; MASTITIS; NONHUMAN; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATTLE; CULTURE MEDIA; ESCHERICHIA COLI; FEMALE; FLUOROQUINOLONES; MASTITIS, BOVINE; MICROSCOPY, ELECTRON, SCANNING;

BACTERIA (MICROORGANISMS); BOS; BOVINAE; ESCHERICHIA COLI;

EID: 84869088044     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.05.036     Document Type: Article

References (15)

1. Abdi-Ali A., Mohammadi-Mehr M., Alaei A.Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 2006, 27:196-200.
2. Andrews A.H., Blowey R.W., Boyd H., Eddy R.G. Bovine Medicine: Diseases and Husbandry of Cattle 2008, Ed. Roca, São Paulo, 1080 p. 2nd ed.
3. Bradley A.J., Green M.J. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J. Dairy Sci. 2009, 92:1941-1953.
4. Chen C., Liao X., Jiang H., Zhu H., Yue L., Li S., Fang B., Liu Y. Characteristics of Escherichia coli biofilm production, genetic typing, drug resistance pattern and gene expression under aminoglycoside pressures. Environ. Toxicol. Pharmacol. 2010, 30:5-10.
5. Du Preez J.H. Bovine mastitis therapy and why it fails. S. Afr. Vet. Assoc. 2000, 71:201-208.
6. Fernandes J.B., Zanardo L.G., Galvão N.N., Carvalho I.A., Nero L.A., Moreira M.A. Escherichia coli from clinical mastitis: serotypes and virulence factors. J. Vet. Diagn. Invest. 2011, 23:1146-1152.
7. Hoeben B.D., Monfardini E., Burvenich C., Hamann J. Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophils. J. Dairy Res. 2000, 67:485-502.
8. Hoffman L.R., D'Argenio D.A., Maccoss M.J., Zhang Z., Jones R.A., Millar S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Lett. Nat. 2005, 436:1171-1175.
9. Huijps K., Hogeveen H., Lam T.J.G.M., Huirne R.B.M. Preferences of cost factors for mastitis management among dairy farmers using adaptive conjoint analysis. Prev. Vet. Med. 2009, 92:351-359.
10. Lago A., Godden S.M., Bey R., Ruegg P.L., Leslie K. The selective treatment of clinical mastitis based on on-farm culture results: II Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival. J. Dairy Sci. 2011, 94:4457-4467.
11. Melchior M.B., Vaarkamp H., Fink-Gremmels J. Biofilms: a role in recurrent mastitis infections?. Rev. Vet. J. 2006, 171:398-407.
12. Melchior M.B., Fink-Gremmels J., Gaastra W. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms. Vet. Microbiol. 2007, 125:141-149.
13. Moreira M.A.S., Oliveira J.A., Teixeira L.M., Moraes C.A. Detection of a chloramphenicol efflux system in Escherichia coli isolated from poultry carcass. Vet. Microbiol. 2005, 109:75-81.
14. Steeneveld W., Werven T., Barkema H.W., Hogeveen H. Cow-specific treatment of clinical mastitis: an economic approach. J. Dairy Sci. 2011, 94:174-188.
15. Suojala L., Simojoki H., Mustonen K., Kaartinen L., Pyörälä S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J. Dairy Sci. 2010, 93:1960-1969.